The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan

被引：0
|
作者：
Takahashi, Makio [1 ]
Itou, Satoru [2 ]
Horiguchi, Shuji [2 ]
Tsuji, Yukie [2 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Osaka, Japan
[2] Kyowa Kirin Co Ltd, Kyowa, Hokkaido, Japan
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
    Hide, Michihiro
    Fukunaga, Atsushi
    Suzuki, Takayuki
    Nakamura, Noriko
    Kimura, Mine
    Sasajima, Takayoshi
    Kiriyama, Junna
    Igarashi, Atsuyuki
    [J]. ALLERGOLOGY INTERNATIONAL, 2023, 72 (02) : 286 - 296
  • [22] Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan
    Takahashi, Makio
    Ito, Satoru
    Tsuji, Yukie
    Horiguchi, Shuji
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 443
  • [23] Safety and effectiveness of riociguat for chronic thromboembolic pulmonary hypertension in real-world clinical practice: interim data from post-marketing surveillance in Japan
    Tanabe, Nobuhiro
    Ogo, Takeshi
    Hatano, Masaru
    Kigawa, Ayaka
    Sunaya, Toshiyuki
    Sato, Shoichiro
    [J]. PULMONARY CIRCULATION, 2020, 10 (03)
  • [24] Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan
    Fukuda, Masaki
    Hattori, Junko
    Ohkubo, Rika
    Watanabe, Asuka
    Maekawa, Shinichiroh
    [J]. CLINICAL DRUG INVESTIGATION, 2024, 44 (07) : 527 - 540
  • [25] Safety and effectiveness of dupilumab in the real-world treatment of atopic dermatitis in Japan: 1-year interim analysis from a post-marketing surveillance
    Saeki, Hidehisa
    Fujita, Hiroyuki
    Suzuki, Katsuhisa
    Arima, Kazuhiko
    [J]. JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 78 - 87
  • [26] Safety and effectiveness of avelumab in patients with curatively unresectable merkel cell carcinoma (MCC) in a real-world setting: A post-marketing surveillance in Japan.
    Uhara, Hisashi
    Kiyohara, Yoshio
    Sato, Masashi
    Endo, Shehla
    Song, Bingbing
    Sato, Yoshinori
    Tanaka, Yutaro
    Kambe, Anzu
    Yamazaki, Naoya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Real-world effectiveness of eculizumab in generalized myasthenia gravis in Japan: 1-year post-marketing surveillance data
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Fukamizu, Yuji
    Osawa, Takehiko
    Kikui, Hidekazu
    Utsugisawa, Kimiaki
    [J]. NEUROLOGY, 2022, 98 (18)
  • [28] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Takashi Ogura
    Yoshikazu Inoue
    Arata Azuma
    Sakae Homma
    Yasuhiro Kondoh
    Katsumi Tanaka
    Kaori Ochiai
    Yukihiko Sugiyama
    Toshihiro Nukiwa
    [J]. Advances in Therapy, 2023, 40 (4) : 1474 - 1493
  • [29] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Ogura, Takashi
    Inoue, Yoshikazu
    Azuma, Arata
    Homma, Sakae
    Kondoh, Yasuhiro
    Tanaka, Katsumi
    Ochiai, Kaori
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1474 - 1493
  • [30] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02): : 85 - 103
12345